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Abstract 
Modulation of gamma oscillations is important for the processing of information and the 
disruption of gamma oscillations is a prominent feature of schizophrenia and Alzheimer’s 
disease. Gamma oscillations are generated by the interaction of excitatory and inhibitory 
neurons where their precise frequency and amplitude are controlled by the balance of 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
excitation and inhibition. Acetylcholine enhances the intrinsic excitability of pyramidal 
neurons and supresses both excitatory and inhibitory synaptic transmission but the net 
modulatory effect on gamma oscillations is not known. Here, we find that the power, but not 
frequency, of optogenetically-induced gamma oscillations in the CA3 region of mouse 
hippocampal slices is enhanced by low concentrations of the broad spectrum cholinergic 
agonist carbachol but reduced at higher concentrations. This bidirectional modulation of 
gamma oscillations is replicated within a mathematical model by neuronal depolarization, but 
not by reducing synaptic conductances, mimicking the effects of muscarinic M1 receptor 
activation. The predicted role for M1 receptors was supported experimentally; bidirectional 
modulation of gamma oscillations by acetylcholine was replicated by a selective M1 receptor 
agonist and prevented by genetic deletion of M1 receptors. These results reveal that 
acetylcholine release in CA3 of the hippocampus modulates gamma oscillation power but not 
frequency in a bidirectional and dose-dependent manner by acting primarily through 
muscarinic M1 receptors. 
 
Introduction 
Gamma oscillations are synchronous network oscillations in the 30-100Hz range found 
throughout the neocortex and hippocampus. The entrainment of neuronal activity to this high 
frequency oscillation is thought to be important for the timing of spikes both within and 
between different brain structures determining the flow of information (Colgin et al., 2009; 
Sohal et al., 2009; Ainsworth et al., 2012). The occurrence of correlated or coherent activity 
at specific behavioral time points is a critical feature of attention and sensory processing 
(Fries et al., 2001; Womelsdorf et al., 2006) and underlies synaptic plasticity required for the 
encoding of long-term memory (Kwag and Paulsen, 2009). Moreover, perturbations of 
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gamma oscillation frequency, power and coherence are found in several cognitive disorders 
including schizophrenia and Alzheimer’s disease (Cho et al., 2006; Verret et al., 2012; 
Gonzalez-Burgos et al., 2015) indicating the importance of gamma oscillations for cognitive 
functions . 
Generation of gamma oscillations in vivo can be achieved by reciprocally connected 
populations of excitatory and inhibitory neurons (Penttonen et al., 1998; Atallah and 
Scanziani, 2009; Cardin et al., 2009; Sohal et al., 2009) (see Figure 4A). This anatomical 
arrangement occurs throughout the neocortex and hippocampus where inhibitory fast-spiking 
parvalbumin positive basket cells (PV BCs) provide feedback inhibition of excitatory 
pyramidal cells (PCs). In the hippocampus gamma oscillations are commonly observed 
“nested” on the phase of theta oscillations (Lisman and Jensen, 2013) but in vitro gamma 
oscillations may also be induced by application of glutamatergic or cholinergic agonists 
(Fisahn et al., 1998; Palhalmi et al., 2004). Gamma oscillation phase can be entrained by 
strong excitatory or inhibitory input to the network (Akam et al., 2012) which is proposed to 
be a mechanism for the generation of different frequencies of gamma within the same brain 
region (Colgin et al., 2009; Jadi and Sejnowski, 2014; Lasztoczi and Klausberger, 2014; 
Schomburg et al., 2014). However, in comparison to their generation, much less is known 
about the mechanisms for modulation of gamma oscillations.  
The release of acetylcholine in the neocortex and hippocampus activates muscarinic and 
nicotinic receptors that regulate the processing of information within these circuits 
(Hasselmo, 2006; Teles-Grilo Ruivo and Mellor, 2013). Muscarinic and nicotinic receptors 
are targeted to specific compartments that enable each subtype to control the function of 
selective nodes within a circuit. For example, M1 muscarinic receptors are principally located 
on somatic and dendritic compartments of PCs (Levey et al., 1995; Yamasaki et al., 2010), 
with some evidence for expression in interneurons (Cea-del Rio et al., 2010; Yi et al., 2014), 
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where they increase excitability by causing the opening of non-selective cationic channels 
and inhibiting K
+
 channels such as M channels and SK channels (Madison et al., 1987; 
Fisahn et al., 2002; Buchanan et al., 2010). Genetic deletion of M1 receptors or 
pharmacological inhibition of muscarinic receptors disrupts memory (Blokland et al., 1992; 
Anagnostaras et al., 2003; Atri et al., 2004; Wess, 2004; Green et al., 2005) whereas 
administration of muscarinic receptor agonists or acetylcholinesterase inhibitors in 
Alzheimer’s disease (Bodick et al., 1997; McGleenon et al., 1999) or muscarinic receptor 
agonists in cognitively impaired humans (Shekhar et al., 2008; Nathan et al., 2013) can 
improve memory. Cholinergic agonists and acetylcholine esterase inhibitors induce gamma 
oscillations in vitro (Fisahn et al., 2002; Spencer et al., 2010) but their role in modulating pre-
existing gamma oscillations and the cholinergic receptor subtypes involved are less well 
characterised.  
To study the mechanisms underlying the modulation of gamma oscillations we made use of 
in vitro and in silico models of gamma oscillations. These systems have previously been used 
to investigate the mechanisms for the generation of gamma oscillations but have rarely been 
employed to determine the mechanisms by which they might be modulated. Using 
optogenetically-induced gamma oscillations in hippocampal CA3 and a mathematical 
network model we show that acetylcholine regulates the power, but not frequency, of gamma 
oscillations in a bidirectional, dose-dependent manner which is mediated by activation of 
muscarinic M1 receptors. 
 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Materials and Methods 
Ethical approval 
All experiments were performed in accordance with the UK Animal Scientific Procedures 
Act (1986) and local guidance from the Home Office Licensing Team at the University of 
Bristol. The protocol was approved by the Animal Welfare and Ethics Review Board at the 
University of Bristol.  
 
Transfection 
53 Wild-type, male, C57/BL6 mice or muscarinic M1 receptor KO mice (M1 KO, bred on a 
C57/BL6 background; line 1784, Taconic (Fisahn et al., 2002)) were used with experiments 
interleaved for wild-type and M1 KOs. p21 – 24 wild-type mice or p25 – 40 M1 KO mice 
underwent stereotaxic surgery to inject virus into the CA3 region of the hippocampus. Under 
inhalation anaesthesia (1-3% O2, 0.5-2% isofluorane) animals were given stereotaxic 
injections of rAAV5-CaMKIIa-hChR2 (H134R)-EYFP virus (Virus Vector Core; 0.5 µl of 
4x10
-12
 T.U. ml
-1
) at the following coordinates: (from bregma, in mm) posterior 2.3, lateral 
2.2, ventral 2.2 (wild-type mice) and posterior 2.46 to 2.80, lateral 2.60 to 2.85, ventral 2.36 
to 3.00 (M1KO mice, coordinates chosen based on animal age). To assess construct 
expression, animals were anaesthetized with intraperitoneal injection of sodium pentobarbital 
(150 mg/kg) and perfused transcardially with 4% paraformaldehyde (Sigma-Aldrich) at 7, 21 
and 35 days after transfection. 60 μm thick brain sections were taken with the aid of a 
freezing microtome and mounted with Vectashield medium (Vector laboratories) containing 
DAPI allowing the visualisation of cell nuclei alongside ChR2-YFP expression under an 
epifluorescence microscope. 
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Slice electrophysiology 
Acute hippocampal slices were prepared 7 - 40 days after transfection for initial 
characterization and 27 – 53 days after transfection for all drug concentration comparisons. 
Animals were decapitated following cervical dislocation, the brain removed and hippocampi 
dissected in ice-cold modified ACSF containing (in mM): 252 sucrose, 2.5 KCl, 26 NaHCO3, 
1 CaCl2, 5 MgCl2, 1.25 NaH2PO4 and 10 glucose. Transverse hippocampal slices of 400 μm 
thickness were cut using a  microslicer (Leica VT1200S) and stored in standard ACSF 
containing (in mM): 119 NaCl, 10 glucose, 26 NaHCO3, 2.5 KCl, 1 NaH2PO4, 2.5 CaCl2 and 
1.3 MgSO4 at room temperature for at least 1 h prior to recording. All solutions were 
saturated with 95% O2, 5% CO2. 
For recording, slices were transferred to a dual perfusion style submerged chamber for 
increased metabolic supply (RC-27L, Warner Instruments). Standard ASCF was perfused at a 
rate of 8.5 ml min
-1
 and recording chamber temperature was maintained at 32-34°C. Slices 
were visualised using infrared differential interference-contrast or fluorescence microscopy 
and YFP fluorescence excited with a 505 nm wavelength LED. Channelrhodopsin was 
excited with a 470 nm wavelength LED through the 4x objective on the microscope.  Local 
field potential (LFP) recordings were made using borosilicate glass pipettes with resistance 3-
6 MΩ when filled with standard ACSF. LFPs were recorded with a multiclamp 700A 
amplifier (Molecular devices), filtered with a Bessel low-pass filter at 200 Hz and sampled at 
10 kHz using a Micro 1401 data acquisition board (CED). No correction was made for 
background 50 Hz noise. Recordings were made using Signal2 software (CED) and analysed 
offline using custom written programs in MATLAB. 
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Mathematical model 
The model for a single cell (node in the network) was based on the model of Kopell et al. 
(Kopell et al., 2010) which uses the Hodgkin-Huxley equation (1) 
 
  
  
         
             
                            
 (1) 
                          (2) 
The membrane potential of both pyramidal cells and interneurons is governed by the 
interaction of sodium (Na), potassium (K) and leak currents (L) as well as an applied current 
(I). Pyramidal cells also contain an additional m-current potassium conductance modelled as 
in (Nowacki et al., 2011) and using VKm = -35mV: equation (2). The applied current takes a 
variety of forms including step, ramp and sine wave functions. In the model, capacitance 
density (C) is measured in µF cm
-2
, voltage (V) in mV and time (t) in ms. The variables gNa, 
gK and gL are the maximal ionic conductances (mS cm
-2
). m, h and n are rate functions which 
determine the gating characteristics of the respective channel and are identical to those given 
in (Kopell et al., 2010).  The gating variables are different between pyramidal and 
interneurons and determine their distinct firing properties. Initial model parameters based on 
(Kopell et al., 2010) are given in Table 1.  
Cells were synaptically coupled in an all-to-all configuration using the following expression: 
                               (3) 
Where gij is the maximal conductance of the synapse, si is the gating variable and Vrev is the 
reversal potential of the synapse. Finally, there was stochastic external drive applied to the 
network to simulate noise. A network of 80 pyramidal cells and 20 interneurons was used to 
simulate oscillatory activity in the model system. Fewer neurons reduced the power and 
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therefore reliability of gamma oscillations whereas more neurons increased simulation time 
without increasing gamma power. Differential equations were solved in MATLAB using the 
midpoint method.  
In order to make comparisons with in vitro data, equation (4) (Bedard et al., 2010) was used 
to give an approximation of LFP. 
     
  
  
 
  
  
           
 (4) 
Where Re is the extracellular resistivity assumed to be 230 Ω cm
-1
, Ij is the sum of the 
currents of cell j, and rj is taken from a normal distribution representing distance between cell 
and position where LFP is recorded. A subpopulation of 40 pyramidal cells and 10 
interneurons was used to calculate LFP  
 
Table 1. Model parameters  
All parameters were based on those used in Kopell et al., 2010. Where changes were made 
the original values from Kopell et al., 2010 are given in grey brackets for comparison. 
Changes in sodium and potassium conductance and reversal potentials were chosen to 
produce waveforms closer to those we observed experimentally and were within the ranges 
used in other similar biophysical modelling studies (Traub et al., 1994; Wang and Buzsaki, 
1996; Ermentrout and Kopell, 1998). 
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Parameters 
Value 
Unit 
Excitatory 
cells 
Inhibitory cells 
Number of cells  
Npr 80 
  
 
Nin 
 
20 
 
 
Capacitance C 1 1 μF cm-2 
Conductances 
Sodium gNa 50 (100) 35 mS cm
-2
 
Potassium gK 20 (80) 9 mS cm
-2
 
Leak gL 0.1 0.1 mS cm
-2
 
M-current gKm 0.5 
 
mS cm
-2
 
Reversal Potentials 
Sodium VNa 50 55 mV 
Potassium VK -70 (-100) -90 mV 
Leak VL -67 -65 mV 
M-current VKm -85 
 
mV 
Synaptic conductances 
E to E  gE-E 0.5 (0) 
 
mS cm
-2
 
I to E gI-E 1.5 
 
mS cm
-2
 
I to I gI-I 
 
0.7 (0.5) mS cm
-2
 
E to I gE-I 
 
1.5 (0.5) mS cm
-2
 
Synaptic reversal 
potentials  
Vrev 0 -80 mV 
Synaptic time constants 
Rise time τR 0.1 0.3 ms 
Decay time τD 3 9 ms 
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Analysis 
Fast fourier transform (FFT) of LFP data were performed to generate power spectral densities 
(PSD) using the chronux toolbox in MATLAB and a 5 taper multi-taper estimate. In all 
experiments baseline PSDs with no stimulation were subtracted from data with stimulation 
input to remove background noise. In every case baseline and stimulation PSDs were 
calculated from downsampled data (1 kHz) and taken from an average of six 2.5s frames. 
Subtracted PSDs were smoothed with a moving average filter with span of 35 data points. 
Gamma oscillation power was calculated as the integral of the PSD between 30 Hz and 100 
Hz and theta oscillation power between 4 Hz and 12 Hz. The peak gamma oscillation 
frequency was measured at the maximum power between 30 Hz and 100 Hz. Gamma and 
theta oscillation power was baseline subtracted within each slice experiment. 
 
Statistics 
Data are plotted as mean ± s.e.m. throughout the manuscript. Kolmogorov-Smirnov test 
showed data were normally distributed. Data for drug concentration comparisons were then 
analysed by one-way ANOVA followed by post-hoc 2-sample t-tests assuming unequal 
variances using Holm-Bonferroni correction to test the null hypothesis that data were the 
same as baseline for each pharmacological manipulation. Experimental numbers for 
statistical analysis were taken as the number of slices used. * denotes p < 0.05, ** p < 0.01, 
*** p < 0.001 and no star denotes p > 0.05. 
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Results 
Optogenetically-induced gamma oscillations in hippocampal slices. 
Excitation of local excitatory and inhibitory networks has been shown to produce gamma 
frequency oscillations in in vitro acute brain slice preparations. In the hippocampus, 
application of glutamatergic or cholinergic agonists provides excitation that generates gamma 
oscillations in the 30-50 Hz range (Buhl et al., 1998; Fisahn et al., 1998; Palhalmi et al., 
2004). However, these persistent gamma oscillations, although robust and therefore amenable 
to experimental manipulation, are not observed in vivo. More recently, gamma oscillations 
have been evoked in vivo and in vitro using transient activation of channelrhodopsin (ChR) to 
provide excitatory drive to the network. This has been achieved in slices of neocortex or 
hippocampus by expressing ChR in neurons which are then stimulated by step, ramp or 
sinusoidal waveforms of light (Adesnik and Scanziani, 2010; Akam et al., 2012; Pastoll et al., 
2013; Butler et al., 2016). In particular, the use of an optogenetically driven theta 
frequency sine wave produces theta nested high frequency gamma comparable to that 
found in vivo. The use of optogenetics to induce gamma oscillations provides a system where 
the modulation of gamma oscillations by pharmacological activation of cholinergic receptors 
may be tested. Therefore, we developed an optogenetic system for inducing gamma 
oscillations in the CA3 region of acute hippocampal slices.  
ChR expression was targeted preferentially to CA3 PCs by stereotaxic injection of a viral 
vector (AAV5) containing ChR (hChR2(H134R)) tagged with YFP under the control of the 
CaMKIIα promoter into the dorsal CA3 region at p21 (see methods). YFP expression 
increased over 35 days post injection (d.p.i, Figure 1A) after which expression levels 
plateaued and appeared strongest in stratum radiatum due to higher membrane density. 
Functional ChR expression was assessed by local field potential (LFP) recording in stratum 
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radiatum in the CA3 area (Figure 1B). 10 ms optical stimulation (470 nm) of a circular area 
encompassing most of the slice evoked LFP responses comprised of slow (onset >8ms after 
the start of light stimulation) and fast (onset <5ms after the start of light stimulation) 
components which were blocked by NBQX (10 μM) and TTX (1 μM) respectively and were 
therefore termed excitatory postsynaptic potentials (EPSPs) and fiber volleys (Figure 1C). A 
residual LFP response was observed in the presence of TTX due to charge flowing through 
ChR. EPSP amplitude increased with increasing light intensity which plateaued around 600-
800µW (Figure 1D).  
We then tested the relative efficacy of step, ramp or sinusoidal waveforms of light 
stimulation for the generation of gamma oscillations in hippocampal slices. A representative 
example of a comparison made in a single slice is shown in Figure 1E. A 1 s step waveform 
(Figure 1Ei) elicited gamma oscillations with peak frequency 61.5 Hz but had a low initial 
power that attenuated rapidly (average power 1.28 x10
-5
 mV
2
). A ramp stimulus to the same 
peak light intensity as the step stimulus induced gamma oscillations with similar peak 
frequency (62.4 Hz) but with higher average power (2.16 x 10
-4
 mV
2
) and less attenuation 
(Figure 1Eii). Moreover, gamma oscillation peak frequency did not vary over the course of 
the ramp stimulation. Hippocampal gamma oscillations in vivo are often observed ‘nested’ 
within an overlying theta (4-12 Hz) oscillation (Bragin et al., 1995). We mirrored this in our 
preparation by stimulating the slice with a 5 Hz or 8 Hz sinusoidal waveform that had the 
same average light intensity as the step waveform (Figure 1Eiii and 1Eiv) (Pastoll et al., 
2013). These stimulations reliably elicited gamma oscillations of higher peak frequency (75.7 
Hz and 78.7 Hz respectively) and comparable average power (6.80 x 10
-5
 mV
2
 and 8.90 10
-5
 
mV
2
) with minimal attenuation. Gamma oscillation peak frequency reduced over sequential 
theta cycles and therefore mean gamma oscillation peak frequency was calculated across the 
entire 1 s stimulation period (Average peak frequency for 5 Hz stimulation was 65.7 ± 3.0 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Hz, n = 54). In accordance with the YFP expression data (Figure 1A), expression levels of 
functional ChR were only sufficient to reliably generate gamma oscillations in response to 5 
Hz stimulation around 28 d.p.i. and induced gamma oscillation power was consistent for 
longer periods of expression post injection (average gamma oscillation power 7.98 x10
-5
 ± 
1.27 x10
-5
 mV
2
, range 27 - 53 d.p.i., n = 54). Given the physiological relevance of theta 
frequency for the generation of gamma oscillations, the 5 Hz sinusoidal waveform 
stimulation protocol was selected for all further experiments and the maximum light 
stimulation intensity was set to the value that elicited a half maximal EPSP response (Figure 
1D).  
In our experimental model, gamma oscillations are hypothesised to be generated by the direct 
reciprocal interaction between glutamatergic CA3 PCs and GABAergic PV BCs (Adesnik 
and Scanziani, 2010; Akam et al., 2012; Pastoll et al., 2013; Butler et al., 2016). We tested 
this by application of glutamatergic or GABAergic antagonists to gamma oscillations induced 
by 5 Hz, theta frequency light stimulation. The AMPA/kainate receptor antagonist NBQX 
was bath applied at increasing concentrations from 0.1 to 10 μM (Figure 2A,B). Gamma 
oscillation power was decreased at concentrations ≥1 μM without affecting peak frequency 
and was reversed after washout of NBQX. The GABAA receptor antagonist picrotoxin (PTX) 
also decreased the power of gamma oscillations in a dose-dependent and reversible manner 
without affecting peak frequency (Figure 2C,D). These results support a model where 
optogenetically-induced theta nested gamma oscillations are generated by reciprocal 
excitatory and inhibitory synaptic connectivity within the CA3 network (Buzsaki and Wang, 
2012).  
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Modulation of optogenetically-induced gamma oscillations by carbachol. 
We next sought to determine whether acetylcholine could modulate gamma oscillations in 
our experimental system. The non-hydrolysable analogue of acetylcholine, carbachol (CCh), 
was bath applied at increasing concentrations from 50 nM to 10 µM. Low concentrations of 
CCh (0.05 and 0.1 μM) caused an increase in gamma oscillation power whereas higher 
concentrations (3 and 10 μM) caused a decrease in gamma oscillation power (Figure 3A,B). 
The peak average frequency of gamma oscillations was not affected by any concentration of 
CCh (Figure 3A,B) and neither was the peak frequency during the first theta cycle nor the 
attenuation of gamma frequency across consecutive theta cycles (Supplementary Figure 1). 
The effects of CCh on the power of gamma oscillations was fully reversed on washout of 
CCh and furthermore, time matched control experiments showed that gamma oscillation 
power and peak frequency did not vary over the course of experiments (Figure 3C). In vivo 
observations indicate that gamma oscillation power is dependent on theta oscillation power 
(Bragin et al., 1995). Therefore, we next analyzed whether CCh had any effect on the power 
of theta oscillations. We found that theta oscillation power remained constant for all 
concentrations of CCh application (Figure 3D) indicating that CCh-induced changes in 
gamma oscillation power were not attributable to changes in theta oscillation power. In 
addition, neither theta nor gamma power were increased outside of optogenetic stimulation 
by these concentrations of carbachol. These results show that CCh induces a bi-directional 
dose-dependent effect on the power of gamma oscillations that is independent of underlying 
theta oscillation power. 
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Modelling the modulation of gamma oscillations by acetylcholine. 
Acetylcholine activates nicotinic α4β2, α3β4 and α7 receptors and muscarinic M1, M2, M3 
and M4 receptors in the hippocampus causing a range of effects including inhibition of 
potassium channels and depolarization (M1 and M3) and regulation of presynaptic calcium 
channels and release of neurotransmitter (M2, M4, α4β2, α3β4 and α7) (Teles-Grilo Ruivo 
and Mellor, 2013). Acetylcholine and its non-hydrolysable analogue carbachol have different 
affinities and efficacies at these cholinergic receptor subtypes (Jensen et al., 2003). To 
investigate the mechanism underlying cholinergic modulation of gamma oscillations and 
identify which cholinergic receptors are involved we developed a biophysical model of CA3 
comprising a network of single compartment Hodgkin-Huxley type neurons, based on the 
work of Kopell et al., (see methods) (Kopell et al., 2010). 80 pyramidal cells and 20 
interneurons were all-to-all connected (Figure 4A), fired action potentials (Figure 4B) and 
exhibited co-ordinated network behavior (Figure 4C). As previously described in 
experimental and theoretical studies (Kopell et al., 2010; Akam et al., 2012), step input to the 
pyramidal cells (1.25 µA cm
-2
) drove the network to fire at gamma frequency (Figure 4Ci) as 
did theta frequency sinusoidal inputs (2.5 µA cm
-2
 maximum amplitude) at 5 Hz or 8 Hz 
(Figure 4Cii, Ciii) thus recapitulating key characteristics of the experimental data. To allow 
comparisons with our experimental results, we used the 5 Hz sinusoidal input in all further 
simulations which produced gamma oscillations with peak frequency 41.2 Hz and average 
power 3.94 x 10
-4
 mV
2
. 
We next tested two hypothesised effects of acetylcholine on gamma oscillations: (i) 
depolarisation of PCs caused by activation of a non-selective cationic conductance and 
inhibition of KCNQ channels (M-current) which model core aspects of muscarinic M1 
receptor activation (Madison et al., 1987; Fisahn et al., 2002), and (ii) reduction of inhibitory 
synaptic transmission which models an aspect of muscarinic M2 and nicotinic α4β2, α3β4 
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and α7 receptor activation (Alkondon and Albuquerque, 2001; Ji et al., 2001; Szabo et al., 
2010; Tang et al., 2011; Teles-Grilo Ruivo and Mellor, 2013). Inhibition of M-current in the 
model had no effect on gamma oscillation power or frequency (Supplementary Figure 2). To 
model the effects of activating a non-selective cationic conductance (which could be voltage 
or calcium dependent) a constant depolarising input current of increasing amplitude was 
applied to PCs in addition to the theta frequency sinusoidal current injection (Figure 5A). 1 
µA cm
-2
 constant input current caused PCs to depolarise from -72.3 ± 1.4 mV to -69.9 ± 2.1 
mV (Figure 5B) and increased the power of gamma oscillations (Figure 5C, D). As input 
current was increased, PCs were more depolarised (to -65.3 ± 0.8 mV at 6 µA cm
-2
) (Figure 
5B) and the power of gamma oscillations was reduced (Figure 5C,D). The peak gamma 
oscillation frequency remained relatively unaffected, within a range of input currents, 
exhibiting only a slight increase (Figure 5D). We then tested the mechanism for the biphasic 
effect on gamma oscillation power by analysing the firing properties of neurons during theta 
frequency excitation. 1 µA cm
-2
 input current to PCs caused both PCs and PV BCs to 
increase their probability of firing across the theta cycle but with the timing of spikes still 
entrained to gamma frequency (Figure 5E). However, as the input current was increased up to 
6 µA cm
-2 
the entrainment to gamma frequency was lost such that PCs, and therefore PV 
BCs, fired at much higher frequencies and the network became desynchronised (Gulyas et al., 
2010) (Figure 5E). These results indicate that activation of M1 mAChRs is sufficient to 
replicate the experimental data for the biphasic modulation of gamma oscillation power by 
carbachol and point towards a mechanism involving an increase in non-selective cation 
conductance rather than inhibition of M-current. 
To model the effects of reducing inhibitory synaptic transmission the inhibitory-to-excitatory 
synaptic conductance (gI-E) was reduced in the model (Figure 6A). Reducing gI-E from 1.5 
mS cm
-2
 to 0.9 mS cm
-2
 prevented gamma oscillations below a value of 1.1 mS cm
-2
 (Figure 
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6B, C). Analysis of neuronal firing during theta frequency stimulation revealed that reducing 
gI-E below 1.1 mS cm
-2 
caused PV BCs to depolarise sufficiently to inactivate Na
+
 channels 
and therefore stop firing action potentials leading to a complete loss of rhythmic network 
activity (Figure 6D). These results suggest that a critical level of gI-E is necessary for gamma 
oscillations but above this threshold gI-E does not modulate either their power or frequency. 
Overall, these simulations predict that the principal effect of acetylcholine – namely the 
bidirectional dose-dependent increase and decrease in gamma oscillation power - could be 
explained solely by the activation of M1 mAChRs although it is possible that the decrease in 
gamma oscillation power at higher concentrations could also be partly mediated by activation 
of other cholinergic receptors that depress inhibitory synaptic transmission.  
Interestingly, both the experimental and simulation data showed a remarkable stability in 
gamma oscillation frequency despite considerable modulation of gamma oscillation power 
across the range of carbachol concentrations (Figure 3) and current injections (Figure 5) 
respectively. The frequency of gamma oscillations has been proposed to be principally 
governed by the activity of, and therefore synaptic input to, interneurons during ongoing 
gamma oscillations (Whittington et al., 1995; Wang and Buzsaki, 1996; Jadi and Sejnowski, 
2014) and therefore we hypothesised that stable gamma oscillation frequency could result 
from stable synaptic input to interneurons during gamma oscillations. We tested this in the 
biophysical model by increasing the interneuron-to-interneuron synaptic conductance (gI-I 
from 0.7 mS cm
-2 
to 1.1 mS cm
-2
), which produced an increase in the net synaptic current 
(calculated by summating the excitatory and inhibitory synaptic currents during the 
simulation period) during gamma oscillations in interneurons but not in pyramidal cells 
(Figure 7A). Furthermore, net synaptic current remained fairly constant across the range of 
constant current injections to the pyramidal cells found to modulate gamma oscillation power 
when gI-I = 0.7 mS cm
-2
 but in contrast, the net synaptic current increased substantially when 
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gI-I = 1.1 mS cm
-2 
as the constant current injection was increased. This suggested that 
increasing inhibitory synaptic conductance between interneurons reduces the stability of net 
synaptic current to interneurons during gamma oscillations and therefore the stability of 
gamma oscillation frequency. Indeed, when we analysed the gamma oscillation frequency 
stability across the range of depolarising current injections we found that using a low gI-I 
produced relatively stable frequencies but when gI-I was increased to 1.1 mS cm
-2 
or 1.5 mS 
cm
-2 
gamma oscillation frequency was much less stable with increasing depolarising current 
(Figure 7B and C). Similarly, using an alternative approach to reduce the excitatory-
inhibitory synaptic balance to interneurons, we found that reducing excitatory synaptic 
conductance onto interneurons (gE-I) from 1.5 mS cm
-2 
to 1.0 mS cm
-2 
or 0.5 mS cm
-2 
also 
produced much less stable gamma oscillation frequencies (Figure 7B and C). These results 
suggest that the gamma oscillation generating network in CA3 of our acute hippocampal 
slices contains interneurons with relatively large excitatory compared to inhibitory synaptic 
inputs.   
 
M1 mAChRs mediate the modulation of gamma oscillations by acetylcholine.  
To test the model predictions we used a combination of pharmacological and genetic 
approaches in the experimental optogenetic model of theta-nested gamma oscillations. The 
simulations predict that M1 mAChR activation is the principal driver of cholinergic 
modulation of gamma oscillations so we tested if M1 mAChR activation was sufficient and 
necessary using a selective M1 mAChR agonist and M1 mAChR knockout mice.  
The M1 mAChR allosteric agonist GSK-5 (Budzik et al., 2010; Dennis et al., 2015) was 
applied to slices in increasing concentrations from 50 nM to 3 µM. In an almost identical 
manner to CCh (Figure 3), GSK-5 produced a bidirectional dose-dependent change in the 
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power of gamma oscillations (Figure 8A,B). Gamma oscillation power increased following 
applications of 50 nM or 100 nM GSK-5 whereas 1 μM or 3 µM caused a decrease in power 
(Figure 8A,B). We have previously found that GSK-5 is not readily removed from slices on 
washout (Dennis et al., 2015) and this was also true for the effects on gamma oscillation 
power. Again, similar to CCh, there was no change in peak gamma oscillation frequency at 
any concentrations of GSK-5 tested (Figure 8B). These results support the mathematical 
model predictions that M1 mAChRs play a key role in the modulation of gamma oscillations 
by acetylcholine. 
To test whether any other cholinergic receptors are important for the modulation of gamma 
oscillations we made use of M1 mAChR knock-out (M1KO) mice (Fisahn et al., 2002; 
Buchanan et al., 2010; Dennis et al., 2015). ChR was expressed in the hippocampus 
following viral injection using the same methods as wild-type mice and gamma oscillations 
of similar peak frequency and power were elicited by 5 Hz sinusoidal stimulation. In slices 
from M1KO mice the effects of CCh application were absent with no increase or decrease in 
the power or peak frequency of gamma oscillations (Figure 8C,D). These results strongly 
indicate that M1 mAChRs are the principal mediators of the bidirectional dose-dependent 
effects of acetylcholine on gamma oscillations. 
 
Discussion 
In this study we employed two separate approaches to investigate the modulation of gamma 
oscillations by acetylcholine. We first developed a model for studying theta-nested gamma 
oscillations using theta frequency optogenetic stimulation of acute hippocampal slices 
(Pastoll et al., 2013; Butler et al., 2016). We found that the broad spectrum cholinergic 
agonist carbachol modulates gamma oscillation power, but not frequency, in a bidirectional 
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and dose-dependent manner. We then tested the mechanism for this bidirectional modulation 
using a mathematical biophysical network model for gamma oscillations (Kopell et al., 2010) 
which predicted that M1 mAChRs were the most likely mediators for the effects of 
acetylcholine. Finally, we tested the model predictions and found that activation of M1 
mAChRs is both sufficient and necessary for the modulation of gamma oscillations by 
acetylcholine. 
Theta-nested gamma oscillations in CA3 region of the hippocampus are generated in vivo by 
the coordinated interactions of excitatory and inhibitory neurons which are triggered by 
excitation of both groups of neurons phase locked to the theta cycle (Buzsaki and Wang, 
2012). This ensures that gamma power strongly covaries with theta power for theta-nested 
gamma (Bragin et al., 1995). Coordinated excitation of excitatory and inhibitory neurons may 
also be provided in vitro in a persistent manner by different pharmacological 
mechanisms including stimulation of kainate receptors, metabotropic glutamate receptors or 
muscarinic receptors (Buhl et al., 1998; Fisahn et al., 1998; Palhalmi et al., 2004). Although 
gamma oscillations are not thought to be triggered directly by activation of these receptors in 
vivo, this strongly suggests that cholinergic receptor activation can modulate theta-nested 
gamma oscillations. The power of theta oscillations in the hippocampus is modulated by 
cholinergic innervation (Lee et al., 1994; Vandecasteele et al., 2014) providing one indirect 
mechanism for the modulation of gamma oscillations by acetylcholine. In contrast, we 
demonstrate a direct mechanism for the modulation of gamma oscillations where theta 
oscillation power and frequency remain constant. 
We found that carbachol modulates the power of gamma oscillations in a bidirectional 
manner which initially suggested two distinct modulatory mechanisms mediated by multiple 
cholinergic receptors with different efficacies. Two potential mechanisms are an increase in 
excitability caused by activation of M1/M3 mAChRs and the decrease in inhibitory synaptic 
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conductance caused by activation of M2 mAChRs or α4β2, α3β4 or α7 nicotinic receptors. 
Indeed, the power and frequency of persistent gamma oscillations generated by kainate have 
been shown to be modulated by nicotinic receptors (Wang et al., 2015). However, the 
frequency of gamma oscillations was unchanged by carbachol. This was surprising because 
acetylcholine has effects on both PV BC excitability and inhibitory synaptic transmission 
(Alkondon and Albuquerque, 2001; Ji et al., 2001; Szabo et al., 2010; Tang et al., 2011; 
Teles-Grilo Ruivo and Mellor, 2013; Yi et al., 2014) which are key determinants of gamma 
oscillation frequency (Whittington et al., 1995; Wang and Buzsaki, 1996; Mann and Mody, 
2010; Oren et al., 2010; Jadi and Sejnowski, 2014). Therefore, our data indicate a limited 
effect of carbachol on gamma oscillations via modulation of inhibition possibly due to a 
lower potency or efficacy at the receptor subtypes regulating inhibition (Jensen et al., 2003). 
In addition, our modelling predicts that networks with high excitatory to inhibitory synaptic 
input ratio will be resistant to modulations in gamma oscillation frequency (Figure 7) 
whereas those with a lower ratio will be less resistant suggesting that different networks may 
vary in their frequency modulation. The lack of a role for M3 mAChRs, which might 
otherwise be expected to perform a similar role to M1 mAChRs, is supported by the 
differential functional expression and distribution of M3 and M1 mAChRs within the 
hippocampus (Porter et al., 2002; Dennis et al., 2015). Indeed, we found that the bidirectional 
modulation of gamma oscillations could be explained entirely by enhancing the excitability 
of PCs caused by activation of M1 mAChRs. 
Optogenetic theta frequency stimulation of entorhinal cortex or hippocampus generates theta-
nested gamma oscillations that exhibit many important properties found in naturally 
occurring theta-nested gamma including the relative timing of excitatory and inhibitory 
neurons within the network (Pastoll et al., 2013; Butler et al., 2016). In addition, since theta 
oscillation frequency and power may be kept constant, optogenetically stimulated theta-
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nested gamma oscillations make an excellent model system to assess the modulation of 
gamma oscillations. Similarly, the mathematical model enabled us to probe the mechanism 
for cholinergic modulation of gamma oscillations by varying the known biophysical 
properties of cholinergic receptor subtype activation producing predictions which were 
subsequently tested experimentally revealing the key role for M1 mAChRs. Although the 
mathematical model was based on experimental biophysical parameters and recapitulated 
many of the core experimental observations it did diverge in some respects to the 
experimental model most notably in the average gamma oscillation frequency which was 
lower in the mathematical model and may indicate potential differences between gamma 
oscillation mechanisms exhibited in the mathematical and experimental models. 
However, the predictions provided by the mathematical model were confirmed in the 
experimental model indicating the validity of the mathematical modelling approach.  
Entrainment of neuronal activity to gamma oscillations is thought to be critical for local 
circuit computations and the transfer of information between brain regions (Colgin et al., 
2009; Sohal et al., 2009; Ainsworth et al., 2012). The coherence and frequency of gamma 
oscillations are therefore critical for cognitive processing. Neuromodulators represent an 
excellent mechanism for modulating gamma oscillations and therefore regulating cognitive 
processing at a local and global level. However, the mechanisms by which neuromodulators 
modulate gamma oscillations are poorly understood. In this study we reveal that the 
neuromodulator acetylcholine modulates the power but not frequency of gamma oscillations 
in the hippocampus. This mechanism could work in tandem with the modulation of theta 
oscillations to mediate the effects of acetylcholine on cognition (Lee et al., 1994; McGaughy 
et al., 2000; Vandecasteele et al., 2014; Okada et al., 2015). Indeed optogenetically induced 
acetylcholine release enhances theta and gamma power in the hippocampus of anaesthetized 
mice but reduces power in both bands in awake mice (Vandecasteele et al., 2014). 
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Acetylcholine is released tonically in the hippocampus at high levels during performance on 
cognitively demanding tasks and to a lesser extent during REM sleep but is generally very 
low during non-REM sleep (or in the anaesthetized state) (Marrosu et al., 1995; Teles-Grilo 
Ruivo et al., 2017). These observations suggest that gamma oscillations may be regulated in a 
bidirectional manner dependent on behavioural state. 
Disruption to gamma oscillations is a prominent feature of schizophrenia and Alzheimer’s 
disease. Cognitive control processes correlate with modulation of gamma oscillations in 
healthy humans but this modulation is absent in schizophrenia (Cho et al., 2006). The 
disruption to gamma oscillations in schizophrenia is believed to result from a reduction in PV 
BC numbers and connectivity (Gonzalez-Burgos et al., 2015). In parallel, disruptions to 
gamma oscillations in Alzheimer’s disease are also thought to follow from a deficit in PV 
BCs and reversing these PV BC deficits in animal models reduces the associated cognitive 
deficits (Verret et al., 2012). An alternative strategy for cognitive enhancement could involve 
modulation of gamma oscillations by agents that target neuromodulator systems. In this study 
we identify one such target as the M1 mAChR. Interestingly, M1 agonists can enhance 
cognition in animals and human models of cognitive deficit (Bodick et al., 1997; Shirey et al., 
2009; Digby et al., 2012; Nathan et al., 2013) supporting M1 mAChRs as a potential 
therapeutic target. Furthermore, our data suggest that the effects of any M1 mAChR agonist 
will be strongly dose-dependent. This, and the high M1 mAChR reserve in the hippocampus 
(Porter et al., 2002), will be important factors for the future development of M1 agonists as 
cognitive enhancers. 
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Figure Legends 
Figure 1. Optogenetic induction of gamma oscillations. 
A. Expression of ChR2-EYFP over time (d.p.i.in top left of each image) after injection of 
rAAV5-CaMKIIa-hChR2 (H134R)-EYFP virus into CA3 region Scalebar is 500 µm. B. 
Schematic diagram illustrating recording electrode placement within stratum radiatum in 
CA3 of acute hippocampal slice. C. Example LFP responses to 10ms light stimulation 
(470nm, 581µW) during control and following NBQX (10 µM) or TTX (1 µM) application. 
D. Amplitude of the LFP response plotted against light intensity (n = 10 slices from 8 
animals). E. Comparison of optogenetic protocols for induction of gamma oscillations. First 
row: Schematic of light stimulation protocol. Column i: 1 s step; column ii: 1 s ramp; column 
iii: 5 Hz sine wave; column iv: 8 Hz sine wave. Subsequent rows show unfiltered LFP, LFP 
bandpass filtered between 30 - 100 Hz, power spectral density plots and spectrograms 
(maximum power given in top right). Data shown are from a single slice.  
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Figure 2. Inhibition of excitatory and inhibitory synaptic connections reduces the power 
of theta-nested gamma oscillations. 
A. Example unfiltered (top) and bandpass filtered (bottom) LFP traces showing response to 5 
Hz sinusoidal light stimulation before, during and after NBQX (10 μM). B. Gamma 
oscillation power but not peak frequency was reduced by NBQX at concentrations of 3 and 
10 μM.  (n = 9 slices from 6 animals; p = 5.89 x 10-5 and 1.92 x 10-8 compared to baseline for 
3 and 10 μM respectively, p > 0.05 for all other concentrations). C. Example unfiltered (top) 
and bandpass filtered (bottom) LFP traces showing response to 5 Hz sinusoidal light 
stimulation before, during and after picrotoxin (PTX, 10 μM). D. Gamma oscillation power 
but not peak frequency was reduced by picrotoxin at concentrations of 3, 10 and 30 μM.  (n = 
8 slices from 6 animals; p = 0.00265, 0.00204 and 0.00349 compared to baseline for 3, 10 
and 30 μM respectively, p > 0.05 for all other concentrations). ** p<0.01, *** p<0.001. 
 
Figure 3. Carbachol induces a dose-dependent bidirectional change in the power of 
theta-nested gamma oscillations. 
A. Example unfiltered (top) and bandpass filtered (2
nd
 row) LFP traces showing response to 5 
Hz sinusoidal light stimulation before, during and after carbachol (0.1 and 10 μM). Power 
spectral density plots and spectrograms (maximum power given in top right) are shown 
below for an example experiment. B. Gamma oscillation power but not peak frequency was 
increased at low concentrations (0.1 μM) of carbachol but reduced at higher concentrations (3 
and 10 μM) (n = 11 slices from 9 animals; p = 0.00383, 0.00350 and 5.950 x 10-8 compared 
to baseline for 0.1, 3 and 10 μM respectively, p > 0.05 for all other concentrations). C. 
Gamma oscillation power and peak frequency were unchanged in time matched control 
experiments (n = 4 slices from 3 animals; p > 0.05 for all time points). D. Theta oscillation 
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power was not changed by any concentration of carbachol (n = 11 slices from 9 animals; p > 
0.05 for all concentrations). ** p<0.01, *** p<0.001. 
 
Figure 4. Theta-nested gamma oscillations in a biophysical network model. 
A. Schematic representation for model connectivity between excitatory (EN) and inhibitory 
(IN) neurons. B. Spiking characteristics of excitatory (top, red) and inhibitory (bottom, blue) 
neurons within the network. C. Network behaviour in response to step (Ci) or 5 Hz (Cii) or 8 
Hz (Ciii) input to excitatory cells with maximal amplitude 2.5 µA cm
-2
. 1
st
 row: Schematic of 
current injection protocol; 2
nd
 row: raster plot of spiking for a network of 80 excitatory (red) 
and 20 inhibitory (blue) neurons; 3
rd
 row: LFP; 4
th
 row: power spectral density plots; 5
th
 row: 
spectrograms (maximum power given in top right). 
 
Figure 5. Modelling the effect of M1 mAChR activation on gamma oscillations. 
A. Schematic representation of depolarizing current given to excitatory neurons within the 
network to model the action of M1 mAChRs. B. Increasing the amount of current injection 
depolarised pyramidal neurons in the mathematical model. C. Power spectral density plots for 
increasing current injections. D. Gamma oscillation power was increased at low current 
injection (1 µAcm
-2
) but reduced at higher current injections (4 and 6 µAcm
-2
) (n = 7; p = 
2.24 x10
-4
, 5.09 x10
-4
, 7.82 x10
-10
 and 5.56 x10
-11
 compared to baseline for 1, 2, 4, 6 and 8 
µAcm
-2
 respectively). E. Example spiking output during sinusoidal input to pyramidal cells 
(black trace overlaid) for excitatory (top) and inhibitory (bottom) neurons over the range of 
constant current injections given to pyramidal neurons. *** p<0.001. 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Figure 6. Modelling the effect of M2 mAChR activation on gamma oscillations. 
A. Schematic representation of reduction in inhibitory-excitatory synaptic conductance (gI-E) 
within the network to model the action of M2 mAChRs. B. Power spectral density plots for 
reduced gI-E. C. Gamma oscillation power was decreased for reduced gI-E (1.0, and 0.9 mS 
cm
-2
) (n = 7; p = 1.59 x 10
-25
 and 1.37 x 10
-23
 compared to baseline for 1.0 and 0.9 mS cm
-2
 
respectively). D. Example spiking output during sinusoidal input to pyramidal cells (black 
trace overlaid) for excitatory (top) and inhibitory (bottom) neurons over the range of gI-E. 
*** p<0.001. 
 
Figure 7. Gamma oscillation frequency stability is governed by synaptic input to 
interneurons.  
A. Net synaptic current density (excitatory synapses are characterised by positive current and 
vice versa) during modelled gamma oscillations induced by theta frequency stimulation 
became more strongly negative in pyramidal cells (left) but less so in interneurons (right) as 
the constant depolarising current increased. Increasing inhibitory-to-inhibitory conductance, 
gI-I, from 0.7 mS cm
-2 
to 1.1 mS cm
-2
 produced no change in net synaptic current density in 
pyramidal cells but became more negative in interneurons particularly with large constant 
depolarising current. B. Gamma oscillation frequency was less stable across a range of 
constant current injections when excitatory-inhibitory synaptic balance was reduced. In 
control conditions (gI-I = 0.7 mS cm
-2
, gE-I = 1.5 mS cm
-2
) gamma oscillation frequency 
increased only slightly with applied depolarising current (fitted plots (left) and slopes (right)). 
When E-I balance was altered by either increasing gI-I or reducing gE-I gamma oscillation 
frequency increased strongly with applied depolarising current (n = 7; p = 8.71 x10
-3
, 6.77 
x10
-4
, 5.10 x10
-3
, 2.54 x10
-8
 for slope comparison control to gI-I = 1.1 mS cm
-2
, gI-I = 1.5 mS 
cm
-2
, gE-I = 1.0 mS cm
-2
, gE-I = 0.5 mS cm
-2
 respectively).  
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Figure 8. M1 mAChRs are necessary and sufficient for the effects of carbachol on theta-
nested gamma oscillations. 
A. Power spectral density plots for theta-nested gamma oscillations with increasing 
concentrations of the M1 mAChR selective agonist GSK-5. B. Gamma oscillation power but 
not peak frequency was increased at low concentrations of GSK-5 (0.05 µM) but reduced at 
higher concentrations (1 and 3 µM) (n = 9 slices from 6 animals; p = 0.0164, 5.90 x10
-3
 and 
7.83 x10
-4
 compared to baseline for 0.05, 1 and 3 µM respectively, p > 0.05 for 0.1 and 0.3 
µM; p > 0.05 for peak frequency at all concentrations). C. Power spectral density plots for 
theta-nested gamma oscillations with increasing concentrations of carbachol in slices from 
M1 KO mice. D. There was no effect of carbachol on gamma oscillation power or peak 
frequency at any concentration of carbachol (n = 9 slices from 6 animals; p > 0.05 for gamma 
power and peak frequency at all concentrations). * p<0.05, ** p<0.01, *** p<0.001. 
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